Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Lupus - like syndrome"'
Autor:
Abdulmecit Yildiz, Mehmet Aydın, Saide Güllülü, Kamil Dilek, Oktay Ünsal, Alparslan Ersoy, Mahmut Yavuz, Mustafa Güllülü, Suat Akgür, Ayşegül Oruç
Publikováno v:
Turkish Journal of Internal Medicine, Vol 2, Iss 3, Pp 91-94 (2020)
Bupropion is a drug used to smoke cessation. Various complications have been reported after using this drug. In a 58-year-old female patient, skin findings and anti-Ro52 positivity developed after the use of this drug. Later, signs of vasculitis appe
Externí odkaz:
https://doaj.org/article/ac12bd728e324e438eac368e8a333695
Publikováno v:
Современная ревматология, Vol 14, Iss 1, Pp 101-107 (2020)
The paper presents data on the pathogenesis of systemic lupus erythematosus (SLE), and depicts various molecular mechanisms for the development of SLE and lupus-like syndromes. It describes groups of diseases, such as apoptotic defects; NETosis; inte
Externí odkaz:
https://doaj.org/article/fb3533fafc9242f4b06b90e53f2e3b55
Autor:
Niccoli L, Nannini C, Blandizzi C, Mantarro S, Mosca M, Di Munno O, Goletti D, Benucci M, Li Gobbi F, Cassarà E, Kaloudi O, Cantini F
Publikováno v:
Therapeutics and Clinical Risk Management, Vol Volume 14, Pp 2097-2111 (2018)
Laura Niccoli,1 Carlotta Nannini,1 Corrado Blandizzi,2 Stefania Mantarro,2 Marta Mosca,3 Ombretta Di Munno,3 Delia Goletti,4 Maurizio Benucci,5 Francesca Li Gobbi,5 Emanuele Cassarà,1 Olga Kaloudi,1 Fabrizio Cantini1 1Department of Rheumatology, Hos
Externí odkaz:
https://doaj.org/article/078003787b1c402fabcbacc50035cd27
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 4, Pp 446-448 (2017)
The paper describes a case of infliximab-induced lupus-like syndrome in a female patient with rheumatoid arthritis and discusses the possible causes of this pathology.
Externí odkaz:
https://doaj.org/article/93c105ff394043d3bbba4aef695ad90c
Autor:
Aysegul Oruc, Kamil Dilek, Mustafa Güllülü, Alparslan Ersoy, Mahmut Yavuz, Mehmet Fethullah Aydin, Saide Güllülü, Oktay Ünsal, Suat Akgur, Abdulmecit Yildiz
Publikováno v:
Volume: 2, Issue: 3 91-94
Turkish Journal of Internal Medicine
Turkish Journal of Internal Medicine
Bupropion is a drug used to smoke cessation. Various complications have been reported after using this drug. In a 58-year-old female patient, skin findings and anti-Ro52 positivity developed after the use of this drug. Later, signs of vasculitis appe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b48c586bbbcbe88723400623e6cc80e
https://doi.org/10.46310/tjim.679421
https://doi.org/10.46310/tjim.679421
Autor:
Dhandapany Gunasekaran, Aakash Chandran Chidambaram, Santhosh Kumar Thangaraju, Kaushik Maulik, Jaikumar Govindaswamy Ramamoorthy, Sanjana Sarangarajan
Publikováno v:
Journal of Clinical Immunology. 41:1696-1700
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c55617c93f10bf84fa151843f92f4411
https://doi.org/10.1007/s10875-021-01096-2
https://doi.org/10.1007/s10875-021-01096-2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hassan Riad, Samya Abu Shaikha, Hamda Al Ansari, Khalifa Al Naama, Hussein Al Sada, Mariam Al Mansoori
Publikováno v:
Case Reports in Dermatology, Vol 5, Iss 2, Pp 219-224 (2013)
Biologics are very useful medications that changed the lives of many patients in the last decade. However, we still do not know about the long-term side effects of these drugs. Infliximab is an anti-TNF chimeric antibody widely used and approved for
Externí odkaz:
https://doaj.org/article/4b4c8896f6e441519795f88ee55ac8e9
Autor:
Markus F. Neurath, Jörg H W Distler, Katharina Dechant, Simon Hirschmann, Christoph Treutlein, Entcho Klenske, Raja Atreya, Sarah Fischer
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Therapeutic Advances in Gastroenterology
Therapeutic Advances in Gastroenterology
Anti-tumor necrosis factor (TNF) antibodies have become an indispensable part in the therapeutic landscape of treating inflammatory bowel disease (IBD) patients. Nevertheless, they can be associated with the occurrence of severe systemic side effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7695db2b3bc89bad085ed788b427b82
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/21702
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/21702
